What does this research mean for the field?

In Chinese NSCLC patients, compound EGFR mutations occur in approximately 8% of cases and are more frequently associated with the EGFR exon 21 p.L858R mutation than with 19-Del, while EGFR exon 20 p.T790M remains the most common mechanism of acquired resistance to EGFR TKIs. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

This study aims to characterize compound EGFR mutations and explore acquired resistance mechanisms in non-small cell lung cancer patients.

June 6, 2026International Journal of Cancer

Landscape of Chinese Lung Cancer Patients With Compound Mutations and Acquired Resistance Alterations: A Retrospective Study

View Full Paper

Ask AI

Bookmark

This study aims to characterize compound EGFR mutations and explore acquired resistance mechanisms in non-small cell lung cancer patients.
Retrospective analysis of next-generation sequencing data from 8849 lung cancer patients
Assessment of 7081 NSCLC tissue samples for mutation spectrum
Evaluation of 77 paired baseline and post-progression samples for resistance mutations.
48.82% of patients had common EGFR mutations, while 7.99% exhibited compound EGFR mutations.
Most resistance was due to EGFR exon 20 p.T790M mutations (71.43%), with RAS/RAF/MEK pathway mutations at 18.18%.
No significant difference in disease progression duration between patients with different EGFR mutations.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Retrospective study identifies compound EGFR mutations and resistance mechanisms in Chinese NSCLC patients, suggesting complex mutation landscapes.

Cite This Study

Huang et al. (2026) studied this question.

synapsesocial.com/papers/6a23baa771a5da9775e764d1 https://doi.org/10.1002/ijc.70545

View Full Paper

Ask AI

Bookmark

Implication

Retrospective study identifies compound EGFR mutations and resistance mechanisms in Chinese NSCLC patients, suggesting complex mutation landscapes.

Landscape of Chinese Lung Cancer Patients With Compound Mutations and Acquired Resistance Alterations: A Retrospective Study

Key Points

Discussion

Implication

Cite This Study

Landscape of Chinese Lung Cancer Patients With Compound Mutations and Acquired Resistance Alterations: A Retrospective Study

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider